Zacks Investment ResearchWed, 03 Jun 2026 16:30:37 GMTBioMarin (BMRN) Up 0.2% Since Last Earnings Report: Can It Continue?BMRN+1.47%
Zacks Investment ResearchThu, 21 May 2026 18:26:22 GMTBioMarin's Voxzogo Meets Goal in Late-Stage Study for HypochondroplasiaBMRN+1.47%
Zacks Investment ResearchTue, 19 May 2026 18:01:17 GMTBMRN Stock Down on Mixed Results From Rare Disease Therapy StudyBMRN+1.47%
Seeking AlphaWed, 06 May 2026 19:48:52 GMTBioMarin: 'Strong Buy' On VOXZOGO Expansion And Amicus AcquisitionBMRN+1.47%
Zacks Investment ResearchTue, 05 May 2026 18:20:16 GMTBioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance RaisedBMRN+1.47%
Seeking AlphaTue, 05 May 2026 01:33:24 GMTBioMarin Pharmaceutical Inc. (BMRN) Q1 2026 Earnings Call TranscriptBMRN+1.47%
Zacks Investment ResearchTue, 05 May 2026 00:30:55 GMTCompared to Estimates, BioMarin (BMRN) Q1 Earnings: A Look at Key MetricsBMRN+1.47%
Zacks Investment ResearchMon, 04 May 2026 22:20:16 GMTBioMarin Pharmaceutical (BMRN) Q1 Earnings Lag EstimatesBMRN+1.47%
Seeking AlphaWed, 15 Apr 2026 16:54:21 GMTBioMarin Pharmaceutical's Rare Disease Portfolio Supplemented By Amicus Acquisition Makes A BuyBMRN+1.47%
